Analyst Price Targets — FIVN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 20, 2026 11:55 am | Rishi Jaluria | RBC Capital | $25.00 | $19.48 | StreetInsider | Five9, Inc (FIVN) PT Lowered to $25 at RBC Capital |
| January 5, 2026 2:38 am | — | Piper Sandler | $21.00 | $18.81 | TheFly | Five9 downgraded to Neutral from Overweight at Piper Sandler |
| December 18, 2025 2:17 pm | Gil Luria | D.A. Davidson | $24.00 | $20.85 | StreetInsider | DA Davidson Reiterates Neutral Rating on Five9, Inc (FIVN) as Shares Expected to Be Range-Bound Near-Term |
| December 18, 2025 11:13 am | Scott Berg | Needham | $40.00 | $21.42 | StreetInsider | Needham Reiterates Buy Rating on Five9, Inc (FIVN) |
| November 7, 2025 11:35 am | Thomas Blakey | Cantor Fitzgerald | $32.00 | $19.87 | StreetInsider | Five9, Inc (FIVN) PT Lowered to $32 at Cantor Fitzgerald |
| October 21, 2025 12:20 pm | Elizabeth Porter | Morgan Stanley | $30.00 | $22.66 | TheFly | Five9 assumed with an Equal Weight at Morgan Stanley |
| September 30, 2025 8:37 pm | — | Wells Fargo | $28.00 | $24.20 | TheFly | Five9 initiated with an Equal Weight at Wells Fargo |
| November 8, 2024 12:24 pm | James Fish | Piper Sandler | $46.00 | $36.65 | StreetInsider | Five9, Inc (FIVN) PT Raised to $46 at Piper Sandler |
| November 8, 2024 10:15 am | Gil Luria | D.A. Davidson | $45.00 | $36.94 | StreetInsider | Five9, Inc (FIVN) PT Raised to $45 at DA Davidson |
| August 21, 2024 7:07 am | Catharine Trebnick | Rosenblatt Securities | $45.00 | $34.66 | StreetInsider | Five9, Inc (FIVN) PT Lowered to $45 at Rosenblatt |
Latest News for FIVN
Five9, Inc. (FIVN) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
PHILADELPHIA, March 02, 2026 (GLOBE NEWSWIRE) -- Corcept Therapeutics, Inc. (NASDAQ: CORT): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Philadelphia, Pennsylvania--(Newsfile Corp. - February 26, 2026) - Grabar Law Office is investigating claims on behalf of long-term Five9, Inc. (NASDAQ: FIVN) shareholders as an underlying securities fraud class action complaint has survived a motion to dismiss. The investigation concerns whether certain officers of the company have breached their fiduciary duties they owed to the company.
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Five9, Inc. (NASDAQ: FIVN) breached their fiduciary duties to shareholders.
NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Five9, Inc. (NASDAQ: FIVN) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Five9 caused the company to misrepresent or fail to disclose that: (i) Five9's net new business was not "strong irrespective of the…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for FIVN.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.